CR9804A - VOLUME INCREASE AGENTS - Google Patents

VOLUME INCREASE AGENTS

Info

Publication number
CR9804A
CR9804A CR9804A CR9804A CR9804A CR 9804 A CR9804 A CR 9804A CR 9804 A CR9804 A CR 9804A CR 9804 A CR9804 A CR 9804A CR 9804 A CR9804 A CR 9804A
Authority
CR
Costa Rica
Prior art keywords
cellulose
ethyl
hydroxy
weight
present
Prior art date
Application number
CR9804A
Other languages
Spanish (es)
Inventor
Thomas Mosko John
Charles Pluta Richard
Michael Glenn David
Puterka Gary
Original Assignee
Mercosul Com Ltda
Estados Unidos De America Representado Por El Secretario De Agricultura Del Departamento Estadounide
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US11/463,883 external-priority patent/US20070037711A1/en
Priority claimed from US11/464,023 external-priority patent/US7781375B2/en
Application filed by Mercosul Com Ltda, Estados Unidos De America Representado Por El Secretario De Agricultura Del Departamento Estadounide filed Critical Mercosul Com Ltda
Publication of CR9804A publication Critical patent/CR9804A/en

Links

Landscapes

  • Compositions Of Macromolecular Compounds (AREA)

Abstract

La presente composicion es capaz de formar una pelicula de particulas e incluye: (a) menos de un 99.65% por peso de al menos una particula; (b) al menos un agente de aumento de volumen escogido del grupo compuesto por: (i) celulosa escogida del grupo compuesto por etil hidroxi etil celulosa, hidroxi etil celulosa, hidroxi propil celulosa, hidroxi etil metil celulosa, hidroxi propil metil celulosa, metil celulosa, etil celulosa y etil metil celulosa y presente en una proporcion mayor al 0.35% por peso y (ii) componente no celulosico o celulosa distinta a la celulosa mencionada en el punto anterior (i) presente en una proporcion de al menos 0.05% por peso y opcionalmente (c) al menos un agente de esparcido. La composicion puede ser utilizada para formar peliculas para uso agricola.The present composition is capable of forming a particle film and includes: (a) less than 99.65% by weight of at least one particle; (b) at least one bulking agent chosen from the group consisting of: (i) cellulose chosen from the group consisting of ethyl hydroxy ethyl cellulose, hydroxy ethyl cellulose, hydroxy propyl cellulose, hydroxy ethyl methyl cellulose, hydroxy propyl methyl cellulose, methyl cellulose, ethyl cellulose and ethyl methyl cellulose and present in a proportion greater than 0.35% by weight and (ii) non-cellulosic or cellulose component other than cellulose mentioned in the previous point (i) present in a proportion of at least 0.05% per weight and optionally (c) at least one spreading agent. The composition can be used to form films for agricultural use.

CR9804A 2005-08-11 2008-03-07 VOLUME INCREASE AGENTS CR9804A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US59586205P 2005-08-11 2005-08-11
US11/463,883 US20070037711A1 (en) 2005-08-11 2006-08-10 Film Forming Spreading Agents
US11/464,023 US7781375B2 (en) 2005-08-11 2006-08-11 Volumizing agents

Publications (1)

Publication Number Publication Date
CR9804A true CR9804A (en) 2008-07-01

Family

ID=44839417

Family Applications (1)

Application Number Title Priority Date Filing Date
CR9804A CR9804A (en) 2005-08-11 2008-03-07 VOLUME INCREASE AGENTS

Country Status (1)

Country Link
CR (1) CR9804A (en)
  • 2008

Similar Documents

Publication Publication Date Title
HN2008000240A (en) VOLUMINIZING AGENTS
CR9803A (en) SPREADING AGENTS FILM TRAINERS
ES2487496T3 (en) Agent to relieve metabolic syndrome
AR069792A1 (en) AGROCHEMICAL COMPOSITION AND METHOD TO PREPARE THE SAME
BR112012010112A2 (en) surgical stapler for application through a small application port and a method of using the stapler to attach a tissue fold
NZ594022A (en) Pharmaceutical composition comprising linagliptin and optionally a sglt2 inhibitor, and uses thereof
CY1116503T1 (en) PHARMACEUTICAL COMPOSITIONS FOR INHIBITION IN THE FORM OF DRY POWDER, SOLUTIONS OR DOLLARS
EA200971081A1 (en) PURINUM DERIVATIVES AND THEIR APPLICATION AS A TALL-SIMILAR RECEPTOR MODULATORS 7
ES2570856T3 (en) Ophthalmic compositions containing a synergistic combination of two polymers
AR064420A1 (en) OPHTHALMIC PHARMACEUTICAL COMPOSITIONS THAT INCLUDE AN EFFECTIVE AMOUNT OF ANALOGS OF 6-AMINOIMIDAZO [1,2B] PIRIDAZINAS, USEFUL FOR THE TREATMENT OF GLAUCOMA AND / OR CONTROL THE NORMAL OR ELEVATED INTRAOCULAR PRESSURE (IOP).
CL2009001025A1 (en) Lozenge composition comprising: a) a standard granule with at least: an alkaline buffering agent, a dissolution modifier and a filler, b) a defined extragranular nicotine active ingredient and at least one alkaline buffering agent; preparation procedure; Useful to eliminate or reduce tobacco use.
AR055095A1 (en) NEW MACROCICLIC INHIBITORS OF HEPATITIS C VIRUS REPLICATION
GT200600307A (en) DOSAGE METHODS OF ORAL DELAYED ORAL DISPOSAL OF OR-DEMETILVENLAFAXIN SUCCINATE
AR070025A1 (en) USE OF DERIVATIVES OF 1-AMINO-ALQUILCICLOHEXANO FOR THE TREATMENT OF COCLEAR TINNITUS AND PHARMACEUTICAL COMPOSITION
NZ734050A (en) Compositions comprising povidone-iodine
AR084932A1 (en) OPHTHALMIC COMPOSITION INCLUDING AN ANDROGEN AND ITS USE FOR THE MANUFACTURE OF A USEFUL MEDICINAL PRODUCT FOR THE TREATMENT OF AN EYE DISEASE RESULTING FROM AN ANDROGENIC DEFICIENCY
AR037448A1 (en) COMPOSITIONS FOR SEED TREATMENT
BRPI0513944A (en) substantially pure form of a quinazoline compound, use of a quinazoline compound and composition
AR076127A1 (en) FORMULATION
BRPI0518781A2 (en) pharmaceutical formulation, process for preparing a pharmaceutical formulation, and use of a compound
MX2020005942A (en) Oral thin film with high active agent loading.
BR0209327A (en) Composition for treatment of drug-induced constipation
GEP20115348B (en) Pharmaceutical composition for treating burns (variants) and methods for the production thereof (variants)
MX2021011995A (en) Aqueous pharmaceutical composition of an anti-il17a antibody and use thereof.
BRPI0506496A8 (en) PHARMACEUTICAL COMPOSITION WITH IMPROVED TOLERANCE AT THE INJECTION SITE COMPRISING SULFOBUTYLETHER-SS-CYCLODEXTRIN AND ITS USE IN THE TREATMENT OF EMESIS INJECTION SITE COMPRISING SULFOBUTYLETHER-SS-CYCLODEXTRIN AND ITS USE IN THE TREATMENT OF EMESIS

Legal Events

Date Code Title Description
FA Abandonment or withdrawal (granting procedure)